The Sexually Transmitted Infections Panel is designed to detect common bacterial and viral infections transmitted through sexual contact.
It combines molecular testing (PCR) with serologic assays to identify active infection or previous exposure.
The panel is used for routine screening, evaluation after potential exposure, or investigation of related symptoms.

What does the panel include?

The panel includes:

• STD PCR – molecular detection of bacterial sexually transmitted infections (such as Chlamydia, Gonorrhea, and others depending on specimen type)
• HIV – serologic testing for HIV antibodies and antigen
• TPHA – serologic test for syphilis (Treponema pallidum)
• VDRL – test used to assess syphilis activity
• HBV – markers for Hepatitis B
• HCV – markers for Hepatitis C

This combination allows broad evaluation of commonly transmitted infections.

Who is this panel suitable for?

• After unprotected sexual contact
• Individuals with multiple sexual partners
• Symptoms such as discharge, burning during urination, genital sores, or rash
• Routine periodic screening
• Before starting a new relationship
• Pre-pregnancy evaluation

The panel is also appropriate for asymptomatic individuals seeking preventive screening.

What is the advantage of a panel over a single test?

Some sexually transmitted infections may remain asymptomatic.
Testing for a single pathogen may miss additional infections.

Combining PCR and serologic testing allows clinicians to:

• Detect active infection
• Identify prior exposure
• Assess stage of syphilis
• Perform simultaneous screening for multiple infections

How is the test performed?

• A venous blood sample is collected for serologic tests
• Urine sample or swab collection for PCR testing, depending on clinical indication
• Fasting is not required
• It is recommended to avoid urination for 1–2 hours before urine PCR collection

How are the results interpreted?

A positive PCR result indicates active infection.
Serologic tests may indicate active or past infection depending on the specific marker.
In some cases, confirmatory or follow-up testing may be required.

⚠️ Interpretation of results requires medical consultation.
Laboratory findings should not be interpreted without full clinical evaluation.

Possible complementary investigations

• HSV testing when indicated
• HPV testing
• Bacterial culture
• Repeat testing based on serologic window period

Further medical evaluation

If results are positive, treatment decisions are made according to the identified infection.

In some cases, repeat testing may be recommended after the window period or to monitor response to therapy.

Consultation may be recommended with:

• Primary care physician
• Dermatologist specializing in venereology
• Infectious disease specialist

Additional Professional Information

All tests are performed in a clinical laboratory operating in accordance with established professional standards and internal quality control procedures.
Results are issued in accordance with validated laboratory protocols.

Interpretation of findings is conducted within the framework of clinical evaluation by the treating physician.